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Membrane potentialLimited uncoupling of oxidative phosphorylation is known to be beneﬁcial in various laboratory models of dis-
eases. The search for cationic uncouplers is promising as their protonophorous effect is self-limiting because
these uncouplers lower membrane potential which is the driving force for their accumulation in mitochondria.
In this work, the penetrating cation Rhodamine 19 butyl ester (C4R1)was found to decreasemembrane potential
and to stimulate respiration of mitochondria, appearing to be a stronger uncoupler than its more hydrophobic
analog Rhodamine 19 dodecyl ester (C12R1). Surprisingly, C12R1 increased H+ conductance of artiﬁcial bilayer
lipid membranes or induced mitochondria swelling in potassium acetate with valinomycin at concentrations
lower than C4R1. This paradox might be explained by involvement of mitochondrial proteins in the uncoupling
action of C4R1. In experiments with HeLa cells, C4R1 rapidly and selectively accumulated in mitochondria and
stimulated oligomycin-sensitive respiration as a mild uncoupler. C4R1 was effective in preventing oxidative
stress induced by brain ischemia and reperfusion in rats: it suppressed stroke-induced brain swelling and
prevented the decline in neurological status more effectively than C12R1. Thus, C4R1 seems to be a promising
example of a mild uncoupler efﬁcient in treatment of brain pathologies related to oxidative stress.ference; BLM,bilayer lipidmem-
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Protection against oxidative stress-related diseases exerted by
protonophorous uncouplers is generally associated with their ability
to reduce ROS production by lowering mitochondrial membranepotential (Δψ) [1,2]. However, high uncoupler concentrations lead to
an arrest of ATP production and impairment of the vitally important
ATP-dependent biochemical reactions. The dependence of ATP produc-
tion on the value of proton motive force is very steep, providing a
“window” between protective and toxic concentrations of anuncoupler.
There is an opinion that this window is quite wide considering that ATP
synthase activity reaches its maximum at rather low Δψ (100–120 mV,
[3–5]) and all values above these are redundant stimulating leak and
hyperbolically inducing ROS generation in mitochondria [1,6]. Modest
(“mild”) uncoupling is the fall of the membrane potential within this
safe window, thus retaining oxidative phosphorylation, while causing
a signiﬁcant drop in the proton leak and the ROS level [6,7]. Even a
small decrease in Δψ initially exceeding the level of approximately
150 mV was shown to disproportionately decrease H2O2 generation
by mitochondria [6–9]. The mild uncoupling phenomenon was sug-
gested to occur in animal cells containing mitochondrial uncoupling
proteins (UCPs) performing two functions, i.e. heat generation and pro-
tection against oxidative injury [10]. According to [11–14], uncoupling
proteins, such as UCP2, play an essential role in protection against
1740 L.S. Khailova et al. / Biochimica et Biophysica Acta 1837 (2014) 1739–1747neurodegenerative diseases (cerebral ischemia, traumatic brain injury
(TBI), and Parkinson's disease).
Stroke is a major cause of death and disability, and it is imperative to
develop therapeutics to mitigate stroke-related injury. It is known that
cell injury and neuronal death after oxidative stress, including ische-
mia/reperfusion of brain, involve structural and functional abnormali-
ties in mitochondria [15]. In view of the above-mentioned relationship
between membrane potential and ROS production in mitochondria,
the neuroprotective effects of conventional uncouplers such as 2,4-dini-
trophenol (DNP) administered in post-reperfusion period in a stroke
model can be easily explained by tightly coupled changes of these two
functions [16]. However, known uncouplers used in the in vivo studies
are toxic thus stimulating the search of those uncouplers which the
living organisms can tolerate.
We have shown in our previous work that long-chain alkyl deriva-
tives of Rhodamine 19 at micromolar concentrations uncouple mito-
chondria by inducing proton ﬂuxes through their inner membrane
[17]. Importantly, as to induced proton transfer, analogs of Rhodamine
B (e.g. C4R4) were inactive due to the presence of additional ethyl
groups, which hinder protonation of one of two nitrogen atoms of the
rhodamine moiety (for chemical structures, see Fig. S1). We have also
reported that C4R1 does not carry protons across liposomal membranes
[17]. In the present study, we show that C4R1 uncouples rat liver mito-
chondria evenmore effectively than the corresponding long-chain Rho-
damine 19 derivatives. We suggest that, similarly to fatty acids that
uncouple mitochondria in an ADP/ATP-antiporter-mediated fashion
[18], C4R1 can uncouple via an interaction with some protein(s) of the
mitochondrial inner membrane. In our previous studies, we demon-
strated that the mitochondria-targeted uncoupler C12R1 exerts signiﬁ-
cant nephroprotection under ischemia/reperfusion of the kidney, as
well as under rhabdomyolysis as inferred from less expressed renal dys-
function judged by elevated level of blood creatinine and urea. Similar
nephroprotective properties were observed for low doses of DNP [19].
In this study, we compared the potency of two Rhodamine 19 deriva-
tives (С4R1 and C12R1) as protective agents in brain ischemia and reper-
fusion. Our results can be relevant to the search for substances causing
mild uncoupling of mitochondria, which are considered to be a promis-
ing therapeutic strategy to treat a number of pathologies [2,20,21].
2. Materials and methods
2.1. Materials
Derivatives of rhodamine were synthesized in our institute by
Natalia V. Sumbatyan and Galina A. Korshunova as described in [22,
23]. Sucrose was from ICN, Rhodamine 6G was from Fluka, and TMRE
and 3,3′-dipropylthiadicarbocyanine iodide (DiSC3-(5)) were from
Molecular Probes. Diphytanoylphosphatidylcholine (DPhPC) was from
Avanti Polar Lipids. Other chemicals were from Sigma-Aldrich.
2.2. Planar phospholipid bilayers
Bilayer lipid membrane (BLM) was formed from 2% decane solution
of DPhPC on a 0.6-mm aperture in a Teﬂon septum separating the ex-
perimental chamber into two compartments of equal size (volumes,
3 ml). Electrical parameters were measured with two AgCl electrodes
placed into the solutions on the two sides of the BLM via agar bridges,
using a Keithley 6517 ampliﬁer (Cleveland, Ohio, USA). The incubation
mixture contained 50 mM Tris–HCl and 50 mM KCl, pH 7.0.
2.3. Isolation of rat liver mitochondria
Rat liver mitochondria were isolated by differential centrifugation
[24] in medium containing 250 mM sucrose, 5 mMMOPS, 1 mM EGTA,
and bovine serum albumin (0.5 mg/ml), pH 7.4. The ﬁnal washing was
performed in medium of the same composition. Protein concentrationwasdetermined using the biuretmethod. Handling of animals and exper-
imental procedures with them were conducted in accordance with the
international guidelines for animal care and use and were approved by
the Institutional Ethics Committee of Belozersky Institute of Physico-
Chemical Biology at Moscow State University.
2.4. Mitochondrial respiration
Respiration of isolated mitochondria was measured using a stan-
dard polarographic technique with a Clark-type oxygen electrode
(Strathkelvin Instruments, UK) at 25 °C using the 782 system software.
The incubation medium contained 250 mM sucrose, 5 mM MOPS,
and 1 mM EGTA, pH 7.4. The mitochondrial protein concentration was
0.8 mg/ml. Oxygen uptake is expressed as nmol/min mg protein.
2.5. Mitochondrial membrane potential measurement
DiSC3-(5)was used as amembranepotential probe [25]. Fluorescence
intensity at 690 nm (excitation at 622 nm) was measured with a Pano-
rama Fluorat 02 spectroﬂuorimeter (Lumex, Russia). The medium for
measurements contained 250 mM sucrose, 20 mMMOPS, 1 mM EDTA,
5 mM succinate, 1 μM rotenone, and 1 μM DiSC3-(5), pH 7.4. The mito-
chondrial protein concentration was 0.4 mg/ml.
2.6. Swelling of mitochondria in potassium acetate
The protonophoric ability of rhodamine derivatives was tested by
induction of swelling of non-respiring rat liver mitochondria incubated
in buffered isotonic potassium acetate in the presence of valinomycin.
Under these conditions, mitochondria do not swell because acetate
can cross themembrane only as undissociated acetic acid, and the trans-
membrane passage of potassium in the form of the K+–valinomycin
complex generates a charge imbalance (Δψ), preventing further perme-
ation of K+ [26]. Intramitochondrial accumulation of potassium acetate
becomes possible only if H+ is exported from the inner compartment
of mitochondria, thus discharging Δψ which limits the swelling.
This H+ export process can be mediated, for example, by synthetic
protonophores [27]. Swelling of mitochondria was recorded as the
decrease in absorbance at 600 nm or 540 nm. Brieﬂy, an aliquot of
mitochondria (0.5 mg mitochondrial protein) was added to 1 ml of
the “swelling medium” containing 145 mM potassium acetate, 5 mM
Tris, 0.5 mM EDTA, 3 μM valinomycin, 1 μM rotenone, pH 7.4.
2.7. Yeast mitochondria
In this study, we used the Yarrowia lipolytica yeast, an obligate aerobe.
The strain was obtained by one of us (R.A.Z.) as a pure isolate from epi-
phytic microﬂora of salt-excreting leaves of arid plants (Negev Desert,
Israel) and identiﬁed as an anamorph of Y. lipolytica (Wick.) van der
Walt and Arx. The yeast cells were routinely grown at 28 °C in agitated
(220 rpm) succinate-containing semi-syntheticmedium to the late expo-
nential growth phase (OD590 = 3.4–3.6). Mitochondria from Y. lipolytica
cells were prepared as described previously (38). They were fully active
for at least 4 h when kept on ice. Oxygen consumption by mitochondria
was monitored amperometrically at room temperature, using the Clark-
type oxygen electrode. The incubation medium contained 0.6 M manni-
tol, 20 mM Tris–pyruvate, 5 mM Tri–-malate, 0.5 mM EGTA, 0.2 mM
Tris–phosphate, pH 7.2–7.4, and mitochondria (0.5 mg protein per ml).
Mitochondrial protein was determined using the Bradford method
(Bradford, 1976) with BSA as the standard.
2.8. FCS experimental setup
Rhodamine uptake by isolated mitochondria was measured by
ﬂuorescence correlation spectroscopy (FCS). Peak intensity analysis
(PIA) records ﬂuorescence time traces of suspensions of dye-doped
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reﬂecting their randomwalk through the confocal volume [28]. The ex-
perimental data were obtained under stirring, which increased the
number of events by about three orders ofmagnitude, thus substantially
enhancing the resolution of themethod. The setup of our own construc-
tion was described previously [28]. Brieﬂy, ﬂuorescence excitation and
detection were provided by a Nd:YAG solid state laser with a 532-nm
beam, attached to an Olympus IMT-2 epiﬂuorescence inverted micro-
scope equipped with a 40×, NA 1.2 water immersion objective (Carl
Zeiss, Jena, Germany). The ﬂuorescence passed through an appropriate
dichroic beam splitter and a long-pass ﬁlter and was imaged onto a
50-μm core ﬁber coupled to an avalanche photodiode (SPCM-AQR-13-
FC, Perkin Elmer Optoelectronics, Vaudreuil, Quebec, Canada). The out-
put signal F(t) was sent to a personal computer, using a fast interface
card (Flex02-01D/C, Correlator.com, Bridgewater, NJ). The signal was
measured in Hz, i.e. number of photons per second. The data acquisition
time Twas 30 s. The card generated the autocorrelation function of the
signal G(τ) deﬁned as
G τð Þ ¼ 1
T
Z T
0
F tð ÞF t þ τð Þdt ¼ bF t þ τð ÞF tð ÞN
2.9. Cultivation of HeLa cells
HeLa cells were cultivated in DMEM with 10% fetal bovine serum
(FBS) and harvested at 70–80% conﬂuency. The cells were washed and
suspended in DMEM without the serum just before measurements.
The ﬁnal cell concentration in the polarographic chamber was 4–5
106 cells/ml. The protein concentration was determined according to
the Lowry protein assay. Oxygen consumption was recorded at 37 °C
as described above.
2.10. Cytoﬂuorimetry of HeLa cells
TheHeLa cellswere cultivated in DMEMwith 10% FBS and 100 nMof
a rhodamine compound. The cells were harvested and analyzed using
ﬂuorescent ﬂow cytometry (Beckman-Coulter FC-500). The Rhodamine
was washed out after 45 min incubation, and the measurement was
continued. Where indicated, 10 μM FCCP was added 30 min before the
Rhodamine.
2.11. Microscopy
HeLa cells were incubated with 100 nM C4R1 or C12R1 and analyzed
without washing out of the ﬂuorescent compound using a pseudo total
internal reﬂection ﬂuorescence (pseudo-TIRF) microscope built upon
an inverted microscope (Nikon Eclipse Ti-E) equipped with a TIRF ob-
jective (Nikon 60×, 1.27 WI). Z-stacks with a step of 0.3 μm were
obtained.
2.12. Middle cerebral artery occlusion model of focal ischemia
Middle cerebral artery occlusion (MCAO) surgery and the sham op-
eration were performed as previously described [29]. Brieﬂy, rats were
anesthetized with i/p injection of 300 mg/kg chloral hydrate. The right
common carotid arterywas exposed through amidline cervical incision.
A heparinized intraluminal silicon-coated monoﬁlament (diameter,
0.25 mm) was introduced via the external carotid artery into the inter-
nal carotid artery to occlude the blood supply to the middle cerebral ar-
tery region. A feedback-controlled heating pad supplemented with an
infrared lamp was used to maintain core temperature (37.0 ± 0.5 °C)
during ischemia. After 60 min of occlusion, the ﬁlament was gently
pulled out and the external carotid artery was permanently closed by
cauterization. In sham-operated rats, the right common carotid artery
was exposed and the external carotid artery was electrocoagulatedwithout introducing the ﬁlament into the internal carotid artery. С4R1
and C12R1 at dose 1 μmol/kg was i/p injected immediately after the
beginning of reperfusion. The rats were randomly divided into the fol-
lowing groups: (1) SHAM + VEHICLE (n = 6), (2) MCAO + VEHICLE
(n=7), (3) MCAO+ С4R1 (n=6), (4) MCAO+ C12R1 (n=6). Infarct
volume was quantiﬁed by analyzing brain MRI images obtained 24 h
after the MCAO as described previously [29]. Brain swelling was
also measured in the MRI images and calculated using the formula:
swelling (edema) = (volume of right hemisphere − volume of left
hemisphere)/volume of left hemisphere [30]. Ischemically damaged
volume for each group was normalized to the mean for the group
MCAO + VEHICLE.
2.13. Limb-placing test
The modiﬁed version of the limb-placing test consisting of seven
tasks was used to assess forelimb and hindlimb responses to tactile
and proprioceptive stimulation [31]. The rats were habituated for han-
dling and tested before operation and after the reperfusion for 24 h.
For each task, the following scores were used: 2 points, normal re-
sponse; 1 point, delayed and/or incomplete response; and 0 points, no
response. Over seven tasks, the mean score was evaluated.
2.14. Analysis of C4R1 accumulation in kidney and brain
Rats were injected i/p with 1 μmol C4R1/kg. After 3 h, the kidney and
brainwere excised, ﬁxedwith 4% formaldehyde in PBS, and sliced using
a VibroSlice microtome (World Precision Instruments, USA) into
100 μm thick sections. Slices were imaged with an LSM510 inverted
confocal microscope (Carl Zeiss Inc., Jena, Germany) with excitation at
543 nm and emission at 560–590 nm. As a negative control, organs
from untreated animals were used.
2.15. Statistics
Statistical analyses were performed using STATISTICA 7.0 for Win-
dows (StatSoft, Inc.). All data are presented as means ± standard
error of means (SEM). Variance homogeneity was assessed with
Levene's test. Statistical differences between groups in the data of in-
farct volume and brain swelling were analyzed using one-way ANOVA
with Tukey's post-hoc test. Statistical differences in the limb-placing
tests between groups were analyzed using the Kruskal–Wallis test
with the Mann–Whitney u-test (the Bonferroni post-hoc correction
was applied). Values for p b 0.05 were assumed to be statistically
signiﬁcant.
3. Results
Our previous ﬁnding of the uncoupling activity of mitochondria-
targeted alkyl rhodamine derivatives [17] pointed to their possible pro-
tective action against oxidative stress-related diseases. Actually, C12R1
proved to be an effective nephroprotector and neuroprotector under
kidney and brain ischemia/reperfusion [19]. To examine the relation-
ship between the anti-oxidative defense exerted by alkyl rhodamine
derivatives and their lipophilicity-dependent uncoupling activity, we
choose the model of MCAO focal ischemia as optimal for evaluation of
the infarct size having low variability [32]. After exposure of the rat
brain to MCAO we observed an extensive cortical and striatal damage
with remarkable brain edema.We examined the effects of i/p injections
of C4R1 or C12R1 on ischemic brain injury of rat after their administra-
tion immediately after restoration of the blood ﬂow to the brain. The
treatment with C4R1 diminished brain swelling almost four fold (from
20 ± 2% to 5.2 ± 1.9%, p b 0.05), while the protective effect of C12R1
was not so remarkable but still signiﬁcantly decreasing the swelling
two fold to 10.4 ± 0.9% (p b 0.05) (Fig. 1A, B). Apart from this, C4R1
and C12R1 provided partial protection of the brain in the experimental
Fig. 1. Protection of ischemia/reperfusion-injured brain by the C4R1 or C12R1 treatment starting immediately after reperfusion. (A) Representative T2-weightedMR-images from coronal
brain sections (0.8 mm thick, from rostral (top) towards caudal (bottom)) obtained 24 h after reperfusion. Hyperintensitive regions refer to ischemic areas depicted in the right hemi-
sphere. Arrows point to themore pronounced edema in the section. (B) Brain edema (swelling) and (C) infarct volumewere evaluated by usingMRI with analysis of T2-weighted images.
(D) Neurological deﬁcit scores estimated in the limb-placing test. * Denotes signiﬁcant difference from theMCAO+ VEHICLE or MCAO groups (p b 0.05) (One-way ANOVA, followed by
Tukey's post-hoc analysis for (B) and (C); Kruskal–Wallis test with the Mann–Whitney U-test for (D)).
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control group, respectively (p b 0.05) (Fig. 1C). The neurological score
after 24 h of reperfusion demonstrates that C4R1 and C12R1 signiﬁcantly
decrease neurological deﬁcit of the ischemic animals. While the intact
rats before the induction of ischemia scored 14 in limb-placing test,
and sham-operated animals scored 13.1± 0.5, in rats exposed to ische-
mia this index was only 2 ± 0.3. The treatment with C4R1 and C12R1
restored the neurological status to 5 ± 0.5 (p b 0.05) and 3.5 ± 0.5, re-
spectively (Fig. 1D). Thus C4R1, in spite of being much less lipophilic
than C12R1, exhibited a higher therapeutic effect.
To shed light on the causes of the unexpectedly high protective
effect of C4R1 in living organisms, we performed comparative measure-
ments of the uncoupling activity of C4R1 and C12R1 in isolated mito-
chondria. We found (Fig. 2A) that C4R1 stimulated respiration of rat
liver mitochondria in State 4 at substantially lower (micromolar) con-
centrations than C12R1 (tens of micromolar). Fig. 2B shows these effects
as a function of C4R1 or C12R1 concentration (with succinate as the sub-
strate). The C50 values for C4R1 and C12R1 were about 1 μM and 30 μM,
respectively. C4R4 and C12R4, which contain no dissociable H+, were
ineffective as uncouplers (data not shown). Their stimulation of respira-
tion supported by glutamate + malate as substrates (curves 1 and 2 of
Fig. 2A) was lower than that with succinate (curves 3 and 4 of Fig. 2A).
The addition of the conventional strong uncoupler FCCP at the end of
the records stimulated respiration with succinate but not with gluta-
mate + malate (Fig. 2A), suggesting an inhibiting effect of an excess
of the rhodamine derivatives on the activity of NADH-dehydrogenase
which is more sensitive to inhibitory effects of other uncouplers thancomplex II and III [33,34]. In Fig. 2C, CCCP, C4R1 and C12R1 are compared
as stimulators and inhibitors of respiration of yeast mitochondria oxi-
dizingNAD-substrates. It is seen that all three compounds ﬁrst stimulat-
ed respiration and then inhibited it when the uncoupler concentration
rose. The window between stimulating and inhibiting concentrations
for C4R1 proved to be as high as 8 times, whereas for C12R1 it was less
than 3.
The analysis of uncoupling activity of the Rhodamine derivatives as a
function of the length of the alkyl chain (substrate, succinate) showed
that C4R1 was the most efﬁcient uncoupler, while a shorter alkyl
(C2R1, i.e. Rhodamine 6G), or longer alkyls (C8R1, C10R1, C12R1, C16R1)
exhibited lower (if any) activity (Fig. 3A). Fig. 3B shows a Rhodamine-
mediated decrease in themitochondrial membrane potential measured
with the potential-sensitive dye DiSC3-(5). In the case of C12R1, the
decrease in the potential was slow and overall less pronounced as
compared to C4R1 (Fig. 3B).
In view of the data on the strong uncoupling activity of C4R1, the low
proton-carrying activity of this compound on lipid vesicles reported
in our previous work [17] seems to be controversial. In the present
study, we used an alternative approach and measured electric diffusion
potential generation on a planar bilayer lipid membrane (BLM), driven
by a transmembrane pH gradient. In this system, addition of FCCP re-
sulted in a transmembrane H+ ﬂux generating an electrical potential
difference across the BLM, the more acidic compartment being nega-
tively charged. We found (Fig. 4) that C12R1 can effectively substitute
for FCCP, whereas C4R1 was less active. The maximal magnitude of the
generated potential was close to the theoretical (Nernstian) limit
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BLM (see also [35]) that was several-folds higher than the conductance
in the presence of C4R1 (data not shown). Thus, the BLM experiments
conﬁrmed the conclusion of our previous data on liposomes [17] that
the protonophorous action of C4R1 on lipid membranes is weaker
compared to that of C12R1.
The inconsistency of the data on the relative efﬁcacy of C4R1
and C12R1 on mitochondrial (Figs. 2,3) and artiﬁcial lipid (Fig. 4)
membranes could be rationalized by the idea of the involvement
of some mitochondrial membrane protein in the process of C4R1-mediated uncoupling, similarly to participation of the ADP/ATP and as-
partate/glutamate antiporters in the fatty acid-mediated uncoupling
[21,36]. Our experiments showed that the inhibitor of the ADP/ATP
carrier, carboxyatractyloside, did not inhibit C4R1-mediated respiration
(data not shown), although it has been found earlier that C2R1 is able
to inhibit the ADP/ATP carrier at low nucleotide concentrations [37].
We also tested the following inhibitors of: calcium uniporter (ruthenium
red), Na+/H+-antiporter (amiloride), Complex I (rotenone), H+-ATPase
(DCCD and oligomycin). Moreover, we also tried 6-ketocholestanol,
which inhibits the action of such potent uncouplers as SF6847 and FCCP
[38]. All these inhibitors had no effect on the C4R1-induced stimulation
of State 4 respiration. Hence, the putative “C4R1-carrier” is outside our
list of candidates or, as in the case of fatty acids, several carriers are
involved.
If C4R1 interacts with a protein located in the matrix or in the inner
mitochondrial membrane, its action must depend on C4R1 accumula-
tion inmitochondria, beingmaximal in the energized state. It has previ-
ously been shown that, in contrast to tetramethylrhodamine ethyl ester
(TMRE), whose accumulation is strongly potential-dependent in cells
and isolated mitochondria, uptake of C12R1 by isolated mitochondria
is rather signiﬁcant even in the de-energized state [39]. Apparently,
Time, s
-50 0 50 100 150 200
D
iff
us
io
n 
po
te
nt
ia
l, 
m
V
0
10
20
30
40
50
∆pH=1
C12R1
C4R1
Fig. 4. Formation of C12R1- or C4R1-mediated H+ diffusion potential on a planar bilayer
phospholipid membrane. The solution contained 10 mM Tris and 100 mM KCl, pH 7.4.
The BLM was made from total lipids of E. coli, and the concentration of C12R1 or C4R1
was 1.0 μM. Arrow, the pH in one of the BLM-separated compartments was shifted to
8.4 by adding KOH.
Time, s
150 200 250 300 350
Ab
so
rb
an
ce
 a
t 6
00
 n
m
0,6
0,7
0,8
0,9
1,0
no additions
C4R1
C12R1
CCCP
A
Time, s
0 100 200 300 400 500 600
Ab
so
rb
an
ce
 a
t 6
00
 n
m
0,7
0,8
0,9
1,0
1,1
1,2
1,3
no additions
FCCP, no Val
C4R1, no Val
C4R1, Val
FCCP, Val
B
Val
Fig. 5. Effect of C12R1 and C4R1 on the swelling of rat liver mitochondria in potassium ac-
etate medium. Incubationmixture: 145mMpotassium acetate, 5 mM TRIS, 0.5mMEDTA,
pH 7.4, and 1 μM rotenone. Mitochondrial protein 0.5 mg/ml. Additions: 4 μMC4R1 (A) or
50 μMC4R1 (B), 4 μMC12R1; 2 μMCCCP, 2 μMFCCP. In A, 1 μMvalinomycinwas present in
all the cases. In B, it was added where indicated.
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compared the energy-dependent uptake by mitochondria of C4R1 and
C12R1 with that of TMRE, using ﬂuorescence correlation spectroscopy
as described previously [39]. Fig. S2 shows that C4R1, similarly
to TMRE and in contrast to C12R1, showed a pronounced component
of energy-dependent uptake. To further analyze the role of Δψ in the
uptake of C4R1 by mitochondria, we measured its protonophorous
activity in non-energized mitochondria. The method of the measure-
ments of mitochondrial swelling in a medium containing potassium
acetate and valinomycin is suitable for addressing this question. It
was previously shown that fatty acids are able to promote this type of
swelling, in agreement with their ability to uncouple mitochondria in
a de-energized state [26]. By contrast, low C4R1 concentrations were
unable to induce swelling of mitochondria under these conditions,
while C12R1was active in this respect (Fig. 5A). These results combined
with the data on uncoupling under energized conditions correlatedwell
with the dependence of the potential-dependent accumulation of C4R1
and C12R1 in mitochondria (Fig. S2). Importantly, increasing the
extramitochondrial concentration of C4R1 from 1 to 50 μM led to induc-
tion of mitochondria swelling comparable to that induced by FCCP even
in non-energized mitochondria (Fig. 5B), a fact conﬁrming the assump-
tion that Δψ was needed to accumulate C4R1 inside mitochondria. It
should be stressed that 50 μM C4R1 operated as a protonophore rather
than a detergent because its effect on swelling was valinomycin-
dependent (Fig. 5B).
Fig. 6 shows the effect of C4R1, C12R1, and FCCP on respiration
of suspended HeLa cells. The respiration was strongly inhibited by
oligomycin, indicating high activity of oxidative phosphorylation in
the cells. In the presence of oligomycin, the respiration was rapidly
stimulated bynanomolar concentrations of C4R1 and reached saturation
at about 1.5 μM (Fig. 6A). Interestingly, in the interval of C4R1 concen-
trations from 50 nM to about 300 nM, the C4R1-stimulated respiration
remained sensitive to oligomycin, indicating that the oxidative phos-
phorylation was not blocked yet under these conditions (Fig. 6A).
Fig. 6B shows the effect of C12R1 on respiration of HeLa cells. In these ex-
periments, the cells were pre-incubated for 2 hwith C12R1 prior tomea-
surements in order to complete the accumulation of C12R1. In the case of
measuring the effect of C12R1 on respiration without pre-incubation,
the acting concentrations of C12R1 were in the range of several micro-
molar, which was much larger than for C4R1 (not shown). In experi-
ments with C12R1 pre-incubation, the acting concentrations of C12R1
were in sub-micromolar range (Fig. 6B). At higher concentrations of
C12R1, the fully uncoupled (FCCP) respiration decreased, indicatinginhibition of the respiratory chain by C12R1 (Fig. 6B). Fig. 6C displays
the titration of HeLa cell respiration with FCCP.
In the next series of experiments, we analyzed accumulation of
the rhodamine conjugates in HeLa cells. Flow cytometricmeasurements
showed that C4R1 accumulated in these cells faster than C12R1 (Fig. 7).
The uncoupler FCCP inhibited accumulation of both rhodamines. The re-
lease of C4R1 from cells after replacing the rhodamine-containingmedi-
um by that without rhodamine was also faster in comparison with
C12R1 (Fig. 7). A signiﬁcant fraction of C12R1 (but not C4R1) remained
associatedwith cells evenwhen FCCPwas added after changing theme-
dium (not shown). Imaging of C4R1 accumulation in substrate-attached
HeLa cells revealed its fast appearance in mitochondria, in contrast to
C12R1, which at ﬁrst stained the plasma membrane and probably the
other intracellular membranes (seen as a diffuse staining) (Fig. S3).
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comparison to C12R1. After extended incubation, both compounds
were selectively accumulated in mitochondria (Fig. S3, 30min images).
The obvious advantage of the rhodamines is their bright
ﬂuorescence, which allows identifying their tissue localization. Fig. S4
shows examples of brain and kidney slices imaged 3 h after i/p injection
of C4R1. The kidney slices exhibited bright ﬂuorescence of C4R1
(Fig. S4A, B), while only limited staining of brain blood vessels was
seen in the case of brain slices (Fig. S4C, D). We conclude that C4R1
permeates through the brain–blood barrier rather slowly. In this con-
text, it seems remarkable that the neuroprotective action of SkQR1
was shown to be partially mediated via synthesis of erythropoietin in
kidney [40].
4. Discussion
Similarly to TMRE and mitochondria-targeted antioxidants (MitoQ,
SkQ), cationic C4R1 electrophoretically accumulates inside mitochon-
dria (organelle interior negative). This accumulation must substantially
increase the biological efﬁciency of these compounds. Moreover, the ef-
fect of any cationic uncouplers should strongly depend on membrane
potential, exhibiting self-limitation of the uncoupling action because
the membrane potential is the driving force for accumulation of these
uncouplers in mitochondria, but, when accumulated, the uncouplers
lowermembrane potential responsible for the accumulation. Consistent
1746 L.S. Khailova et al. / Biochimica et Biophysica Acta 1837 (2014) 1739–1747with this statement, low concentrations of C4R1 had no effect on
the proton permeability of mitochondria in their non-energized
state as assessed by swelling in potassium acetate in the presence of
valinomycin (Fig. 5). With respect to Δψ dependence, uncoupling by
C4R1 resembles that exerted by a natural uncoupler, UCP1, which
shows high H+ conductance only at membrane potential above some
threshold [41]. Inability of low C4R1 concentrations to induce H+ con-
ductance in lipid membranes can most probably be related to its poor
binding to the membrane.
A general scheme of the operation of C4R1 as an inducer of H+
conductance in mitochondria might be the following. (1) C4R1 accu-
mulates electrophoretically in the interior ofmitochondria. (2) Accu-
mulation of C4R1 inside mitochondria results in saturation of the
inner mitochondrial membrane with C4R1, including the binding of
C4R1 to inner membrane protein(s) that facilitate transmembrane
movement of protonated (cationic) form, which is the rate-limiting
step. (3) Electroneutral (deprotonated) C4R1 crosses the membrane in
a protein-independent manner. This hypothesis explains the essential
features of the C4R1-mediated uncoupling phenomenon: (a) lower efﬁ-
ciency of small C4R1 concentrations in the bilayer lipid membrane
(where no proteins are present), (b) requirement of energization of mi-
tochondria to createH+-conductance (which is necessary to accumulate
C4R1 inside mitochondria), (c) inefﬁciency of C4R4 (lacking ionizable
H+), and (d) in mitochondria, higher efﬁciency of C4R1 compared to
C12R1, the latter being assumed to be unable to be recognized by the
protein carriers. The identiﬁcation of these putative mitochondrial pro-
teins is a task of our future work.
Limited uncoupling induced by low doses of uncouplers was shown
to lead to favorable therapeutic action in a number of laboratory animal
models [2]. It was suggested that certain pathological processes in neu-
rons proceed via the induction of nonspeciﬁc permeability of mito-
chondria and the accumulation of high levels of Ca2+ associated with
excessive generation of ROS [42–44], which can lead to either apoptotic
or necrotic cell death [45]. In our experiments, we have demonstrated
that treatment with mitochondria-targeted uncouplers resulted in a
signiﬁcant reduction in the brain damage and swelling as well as better
behavioral outcomes than measured in vehicle-treated animals. These
results highlight the importance of early adverse mitochondrial events
in brain damage during ischemia/reperfusion and support the concept
that “mild” mitochondrial uncoupling may be an important neuropro-
tective strategy for the treatment of stroke and other brain pathologies
associated with cellular oxidative stress. C4R1 and C12R1 exhibited sim-
ilar protective action on the volume of ischemic damage, while C4R1
was substantially more active than C12R1 in the reduction of brain
swelling and brain function distortion. Some uncoupling activity of
C12R1 can be explained by proton cyclingwithout assistance of any pro-
tein and/or by translocation of anions of fatty acids [46].
As previously demonstrated, the classical uncouplers DNP and FCCP
are neuroprotectors. Using the model of Parkinson's disease studied on
slices of rat brain, it has been shown that DNP and FCCP signiﬁcantly an-
tagonized and delayed the ability of rotenone to potentiate ion currents
evoked by N-methyl-D-aspartate [47]. In a study by Pandya et al., DNP
and FCCPwere used at an optimal dose of 5 and 2.5 mg/kg, correspond-
ingly, after intervention 5-min-post-injury on the model of trauma.
They found that these substances improve brainmitochondrial function
and neurological outcomes [48,49]. Similar results were obtained for
DNP used after post-reperfusion administration with the stroke model
[16]. The neuroprotective efﬁcacy of DNP was conﬁrmed in a chemical
model of neurodegeneration [50]. Unfortunately, DNP has a very nar-
row therapeutic window, since in rodents the toxic concentrations of
DNP exceeded therapeutic concentration by only 2-3-fold [50,51].
DNPwaswidely used in clinical practice forweight loss in the beginning
of the 20th century, but it was banned for the market by the FDA due to
several deaths caused by side-effects associatedwith overdosing and se-
vere uncoupling ofmitochondria [52]. C4R1, as a self-limiting uncoupler,
may be a stepping-stone to creation of an artiﬁcial inducer of a UCP1-like “mild” uncoupling with a therapeutic window much larger than
the classical (anionic) protonophores.
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